<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01521806</url>
  </required_header>
  <id_info>
    <org_study_id>HM001</org_study_id>
    <nct_id>NCT01521806</nct_id>
  </id_info>
  <brief_title>Effects of Dietary Fiber on Insulin Sensitivity</brief_title>
  <official_title>Effects of Dieatry Fiber on Insulin Sensitivity in Pre- and Post-menopausal Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ingredion Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ingredion Incorporated</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will examine the effects of a dietary fiber on insulin sensitivity in overweight
      and obese women. The fiber will be added to snack foods and women will consume the foods for
      four weeks. In one four-week period, 15 g of fiber will be added, and 30 g will added in
      another period. In a third period, no fiber will be added to the snack foods. Insulin
      senstivity will be measured at the end of each treatment period.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">September 2013</completion_date>
  <primary_completion_date type="Anticipated">January 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Insulin sensitivity</measure>
    <time_frame>5-hr test, performed 3 times within a 20-week period</time_frame>
    <description>A frequently sampled intravenous blood glucose tolerance test will be performed.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mitocondrial function</measure>
    <time_frame>3 times, with a 20-week period</time_frame>
    <description>A muscle biospy will be taken to assess mitochondrial function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Meal tolerance test</measure>
    <time_frame>3 times, within a 20-week period</time_frame>
    <description>A high-fat meal will be given and blood will be drawn over a three-hr period</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Focus of the Study is Insulin Sensitivity</condition>
  <arm_group>
    <arm_group_label>Low dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>15 g of fiber per day will be added to snack foods</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High dose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>30 g of fiber per day will be added to snack foods</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No fiber</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Snack foods without fiber will be given</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Dietary Fiber</intervention_name>
    <description>Dietary fiber will be added to snack foods</description>
    <arm_group_label>Low dose</arm_group_label>
    <arm_group_label>High dose</arm_group_label>
    <arm_group_label>No fiber</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Impaired fasting glucose

          -  Overweight and obese

        Exclusion Criteria:

          -  Diabetes, Presence of chronic diseases
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Barbara Gower, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Brandon Kane</last_name>
    <phone>205-975-9629</phone>
    <email>kane003@uab.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clinical Research Unit</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35249</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Brandon Kane</last_name>
      <phone>205-975-9629</phone>
      <email>kane003@uab.edu</email>
    </contact>
    <investigator>
      <last_name>Barbara Gower, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.uab.edu/cores/clinical-research-unit-cru</url>
    <description>clinical center</description>
  </link>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 20, 2012</study_first_submitted>
  <study_first_submitted_qc>January 26, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 31, 2012</study_first_posted>
  <last_update_submitted>January 26, 2012</last_update_submitted>
  <last_update_submitted_qc>January 26, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 31, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>insulin sensitivity</keyword>
  <keyword>resistant starch</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypersensitivity</mesh_term>
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>April 20, 2016</submitted>
    <returned>May 26, 2016</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

